Literature DB >> 12208939

In vitro intersubtype recombinants of human immunodeficiency virus type 1: comparison to recent and circulating in vivo recombinant forms.

Miguel E Quiñones-Mateu1, Yong Gao, Sarah C Ball, Andre J Marozsan, Awet Abraha, Eric J Arts.   

Abstract

The increased prevalence of human immunodeficiency virus type 1 (HIV-1) intersubtype recombinants (ISRs) is shaping HIV-1 evolution throughout the world and will have an impact on both therapeutic and vaccine strategies. This study was designed to generate and compare in vitro ISRs to those isolated from HIV-infected individuals throughout the world. Human peripheral blood mononuclear cells were dually infected with seven pairs of HIV-1 isolates from different subtypes (i.e., A to F). Recombinant crossover sites were mapped to specific regions in the envelope (env) gene by using a cloning-hybridization technique and subtype-specific probes. In vitro intersubtype recombination was at least twofold more frequent in the V1-to-V3 region than in any other env fragment, i.e., C1 to V1, V3 to V5, or V5 to gp41. Sequence and recombination site analyses suggested the C2 env domain as a "hot region" for recombination and selection of replication-competent ISRs during the 15-day incubation. In addition to these regional preferences for env recombination, homopolymeric nucleotide tracts, i.e., sequences known to pause reverse transcriptase and promote template switching, were found in most in vitro crossover sites. ISRs, originating from recent dual infections and limited transmission events, partly retained this in vitro regional or sequence preference for recombination sites. However, a shift to crossover sites flanking the gp120-coding sequence was evident in the stable circulating recombinant forms of HIV-1. Based on these findings, HIV-1 recombinants generated from these dual infections may be used as a model for in vivo intersubtype recombination and for the design of various diagnostic assays and vaccine constructs.

Entities:  

Mesh:

Year:  2002        PMID: 12208939      PMCID: PMC136488          DOI: 10.1128/jvi.76.19.9600-9613.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  HIV-1 diversity in Brazil: genetic, biologic, and immunologic characterization of HIV-1 strains in three potential HIV vaccine evaluation sites. Brazilian Network for HIV Isolation and Characterization.

Authors:  V Bongertz; D C Bou-Habib; L F Brígido; M Caseiro; P J Chequer; J C Couto-Fernandez; P C Ferreira; B Galvão-Castro; D Greco; M L Guimarães; M I Linhares de Carvalho; M G Morgado; C A Oliveira; S Osmanov; C A Ramos; M Rossini; E Sabino; A Tanuri; M Ueda
Journal:  J Acquir Immune Defic Syndr       Date:  2000-02-01       Impact factor: 3.731

2.  HIV-1 nomenclature proposal.

Authors:  D L Robertson; J P Anderson; J A Bradac; J K Carr; B Foley; R K Funkhouser; F Gao; B H Hahn; M L Kalish; C Kuiken; G H Learn; T Leitner; F McCutchan; S Osmanov; M Peeters; D Pieniazek; M Salminen; P M Sharp; S Wolinsky; B Korber
Journal:  Science       Date:  2000-04-07       Impact factor: 47.728

3.  Mutations of the kissing-loop dimerization sequence influence the site specificity of murine leukemia virus recombination in vivo.

Authors:  J G Mikkelsen; A H Lund; M Duch; F S Pedersen
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

4.  High rate of recombination throughout the human immunodeficiency virus type 1 genome.

Authors:  A E Jetzt; H Yu; G J Klarmann; Y Ron; B D Preston; J P Dougherty
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

5.  RNA motifs mediating in vivo site-specific nonhomologous recombination in (+) RNA virus enforce in vitro nonhomologous crossovers with HIV-1 reverse transcriptase.

Authors:  M Figlerowicz; A Bibiłło
Journal:  RNA       Date:  2000-03       Impact factor: 4.942

6.  Characterization of (+) strand initiation and termination sequences located at the center of the equine infectious anemia virus genome.

Authors:  S R Stetor; J W Rausch; M J Guo; J P Burnham; L R Boone; M J Waring; S F Le Grice
Journal:  Biochemistry       Date:  1999-03-23       Impact factor: 3.162

7.  Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya.

Authors:  J R Neilson; G C John; J K Carr; P Lewis; J K Kreiss; S Jackson; R W Nduati; D Mbori-Ngacha; D D Panteleeff; S Bodrug; C Giachetti; M A Bott; B A Richardson; J Bwayo; J Ndinya-Achola; J Overbaugh
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

8.  A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression.

Authors:  M E Quiñones-Mateu; S C Ball; A J Marozsan; V S Torre; J L Albright; G Vanham; G van Der Groen; R L Colebunders; E J Arts
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

9.  Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.

Authors:  C Bruce; C Clegg; A Featherstone; J Smith; B Biryahawaho; R Downing; J Oram
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

10.  Genetic variation of HIV type 1 in four World Health Organization-sponsored vaccine evaluation sites: generation of functional envelope (glycoprotein 160) clones representative of sequence subtypes A, B, C, and E. WHO Network for HIV Isolation and Characterization.

Authors:  F Gao; L Yue; S Craig; C L Thornton; D L Robertson; F E McCutchan; J A Bradac; P M Sharp; B H Hahn
Journal:  AIDS Res Hum Retroviruses       Date:  1994-11       Impact factor: 2.205

View more
  28 in total

1.  MinPD: distance-based phylogenetic analysis and recombination detection of serially-sampled HIV quasispecies.

Authors:  Patricia Buendia; Giri Narasimhan
Journal:  Proc IEEE Comput Syst Bioinform Conf       Date:  2004

2.  Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule.

Authors:  Lina Josefsson; Martin S King; Barbro Makitalo; Johan Brännström; Wei Shao; Frank Maldarelli; Mary F Kearney; Wei-Shau Hu; Jianbo Chen; Hans Gaines; John W Mellors; Jan Albert; John M Coffin; Sarah E Palmer
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

3.  An in vitro Model to Mimic Selection of Replication-Competent HIV-1 Intersubtype Recombination in Dual or Superinfected Patients.

Authors:  Bernard S Bagaya; Meijuan Tian; Gabrielle C Nickel; José F Vega; Yuejin Li; Ping He; Katja Klein; Jamie F S Mann; Wei Jiang; Eric J Arts; Yong Gao
Journal:  J Mol Biol       Date:  2017-05-01       Impact factor: 5.469

4.  HIV-1 conserved-element vaccines: relationship between sequence conservation and replicative capacity.

Authors:  Morgane Rolland; Siriphan Manocheewa; J Victor Swain; Erinn C Lanxon-Cookson; Moon Kim; Dylan H Westfall; Brendan B Larsen; Peter B Gilbert; James I Mullins
Journal:  J Virol       Date:  2013-03-06       Impact factor: 5.103

5.  Comparison of the genetic recombination rates of human immunodeficiency virus type 1 in macrophages and T cells.

Authors:  Jianbo Chen; Terence D Rhodes; Wei-Shau Hu
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

6.  Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression.

Authors:  Ryan M Troyer; Kalonji R Collins; Awet Abraha; Erika Fraundorf; Dawn M Moore; Randall W Krizan; Zahra Toossi; Robert L Colebunders; Mark A Jensen; James I Mullins; Guido Vanham; Eric J Arts
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

7.  Mechanism analysis indicates that recombination events in HIV-1 initiate and complete over short distances, explaining why recombination frequencies are similar in different sections of the genome.

Authors:  Sean T Rigby; April E Rose; Mark N Hanson; Robert A Bambara
Journal:  J Mol Biol       Date:  2009-02-20       Impact factor: 5.469

8.  High rates of human immunodeficiency virus type 1 recombination: near-random segregation of markers one kilobase apart in one round of viral replication.

Authors:  Terence Rhodes; Heather Wargo; Wei-Shau Hu
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

9.  Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assay.

Authors:  Amit Kapoor; Morris Jones; R W Shafer; Soo-Yon Rhee; Powel Kazanjian; Eric L Delwart
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

10.  Relationships between infectious titer, capsid protein levels, and reverse transcriptase activities of diverse human immunodeficiency virus type 1 isolates.

Authors:  Andre J Marozsan; Erika Fraundorf; Awet Abraha; Heather Baird; Dawn Moore; Ryan Troyer; Immaculate Nankja; Eric J Arts
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.